Use of hydroxocobalamin to treat intraoperative vasoplegic syndrome refractory to vasopressors and methylene blue during liver transplantation
Clinical Transplantation · 2024
DOI: 10.1111/ctr.15271 ↗At a glance
Journal article in Clinical Transplantation, 2024. Written by Sher-Lu Pai and 8 co-authors. Institution: Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Jacksonville, Florida, USA. Major MEDLINE topics: Vasoplegia, Liver Transplantation. Cited 10 times so far (Crossref); 43 references.
Abstract (original language)
Introduction
For patients with catecholamine‐resistant vasoplegic syndrome (VS) during liver transplantation (LT), treatment with methylene blue (MB) and/or hydroxocobalamin (B12) has been an acceptable therapy. However, data on the effectiveness of B12 is limited to case reports and case series.
Methods
We retrospectively reviewed records of patients undergoing LT from January 2016 through March 2022. We identified patients with VS treated with vasopressors and MB, and abstracted hemodynamic parameters, vasopressor requirements, and B12 administration from the records. The primary aim was to describe the treatment efficacy of B12 for VS refractory to vasopressors and MB, measured as no vasopressor requirement at the conclusion of the surgery.
Results
One hundred one patients received intraoperative VS treatment. For the 35 (34.7%) patients with successful VS treatment, 14 received MB only and 21 received both MB and B12. Of the 21 patients with VS resolution after receiving both MB and B12, 17 (89.5%) showed immediate, but transient, hemodynamic improvements at the time of MB administration and later showed sustained response to B12.
Conclusion
Immediate but transient hemodynamic response to MB in VS patients during LT supports the diagnosis of VS and should prompt B12 administration for sustained treatment response.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Jacksonville, Florida, USA.
- Department of Anesthesiology, Perioperative and Pain Medicine, The Mount Sinai Hospital, New York, New York, USA.
- Department of Anesthesiology, University of Florida Health, Gainesville, Florida, USA.
- Department of Quantitative Health Science, Mayo Clinic, Jacksonville, Florida, USA.
ORCID profiles: Sher-Lu Pai, Ilana I Logvinov, Ryan Chadha, Stephen Aniskevich
Cite
APA
Pai, S. L., Torp, K. D., Insignares, V. C., DeMaria, S., Giordano, C. R., Logvinov, I. I., Li, Z., Chadha, R., & Aniskevich, S. (2024). Use of hydroxocobalamin to treat intraoperative vasoplegic syndrome refractory to vasopressors and methylene blue during liver transplantation. Clinical Transplantation. https://doi.org/10.1111/ctr.15271
Vancouver
Pai SL, Torp KD, Insignares VC, DeMaria S, Giordano CR, Logvinov II, et al. Use of hydroxocobalamin to treat intraoperative vasoplegic syndrome refractory to vasopressors and methylene blue during liver transplantation. Clinical Transplantation. 2024. doi:10.1111/ctr.15271
BibTeX
@article{Pai2024,
author = {Pai, Sher-Lu and Torp, Klaus D and Insignares, Vianca C and DeMaria, Samuel and Giordano, Chris R and Logvinov, Ilana I and Li, Zhuo and Chadha, Ryan and Aniskevich, Stephen},
title = {Use of hydroxocobalamin to treat intraoperative vasoplegic syndrome refractory to vasopressors and methylene blue during liver transplantation},
journal = {Clinical Transplantation},
year = {2024},
doi = {10.1111/ctr.15271}
}
EUVIMED